BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22406264)

  • 41. A loss-of-function cysteine mutant in fibulin-3 (EFEMP1) forms aberrant extracellular disulfide-linked homodimers and alters extracellular matrix composition.
    Woodard DR; Daniel S; Nakahara E; Abbas A; DiCesare SM; Collier GE; Hulleman JD
    Hum Mutat; 2022 Dec; 43(12):1945-1955. PubMed ID: 35998264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tumor invasion requires disulfide bond reduction of the extracellular matrix].
    Ros M; Bard F; Saltel F
    Med Sci (Paris); 2021 Apr; 37(4):322-324. PubMed ID: 33908847
    [No Abstract]   [Full Text] [Related]  

  • 43. Passing the post: roles of posttranslational modifications in the form and function of extracellular matrix.
    Adams JC
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1179-C1197. PubMed ID: 36912485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice.
    Rende U; Ahn SB; Adhikari S; Moh ESX; Pollock CA; Saad S; Guller A
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endoplasmic reticulum stress and glutathione therapeutics in chronic lung diseases.
    Janssen-Heininger Y; Reynaert NL; van der Vliet A; Anathy V
    Redox Biol; 2020 Jun; 33():101516. PubMed ID: 32249209
    [No Abstract]   [Full Text] [Related]  

  • 46. Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1-α is a poor prognostic marker for non-small cell lung cancer.
    Kim KM; An AR; Park HS; Jang KY; Moon WS; Kang MJ; Lee YC; Ku JH; Chung MJ
    Oncol Lett; 2018 Nov; 16(5):5753-5760. PubMed ID: 30344729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ROLE OF THIOLS IN OXIDATIVE STRESS.
    Baba SP; Bhatnagar A
    Curr Opin Toxicol; 2018 Feb; 7():133-139. PubMed ID: 30338308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
    Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
    Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion.
    Wu J; Chen XH; Wang XQ; Yu Y; Ren JM; Xiao Y; Zhou T; Li P; Xu CD
    Oncotarget; 2015 May; 6(14):11794-805. PubMed ID: 25940440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis.
    Uematsu S; Goto Y; Suzuki T; Sasazawa Y; Dohmae N; Simizu S
    FEBS Open Bio; 2014; 4():879-85. PubMed ID: 25379385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GRP78 promotes the invasion of pancreatic cancer cells by FAK and JNK.
    Yuan XP; Dong M; Li X; Zhou JP
    Mol Cell Biochem; 2015 Jan; 398(1-2):55-62. PubMed ID: 25218495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.
    Farina AR; Mackay AR
    Cancers (Basel); 2014 Jan; 6(1):240-96. PubMed ID: 24473089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoregulation through membrane proteins modified by reducing conditions induced by immune reactions.
    Stegmann M; Metcalfe C; Barclay AN
    Eur J Immunol; 2013 Jan; 43(1):15-21. PubMed ID: 23233323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
    Vandooren J; Van den Steen PE; Opdenakker G
    Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
    Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
    Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
    Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
    Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
    Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9.
    Khan MM; Simizu S; Suzuki T; Masuda A; Kawatani M; Muroi M; Dohmae N; Osada H
    Exp Cell Res; 2012 May; 318(8):904-14. PubMed ID: 22406264
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.